| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/10/2008 | US20080008767 Methods And Compositions For Controlling Parasitic Infections Of Animals |
| 01/10/2008 | US20080008765 Taste-Masking Pharmaceutical Compositions |
| 01/10/2008 | US20080008764 Carbon-substituted diketopiperazine delivery systems |
| 01/10/2008 | US20080008762 Steroid Formulation And Methods Of Treatment Using Same |
| 01/10/2008 | US20080008759 Method of improving wound healing |
| 01/10/2008 | US20080008758 Granulate-matrix |
| 01/10/2008 | US20080008755 Pharmaceutical formulation of cholanic acid-chitosan complex incorporated with hydrophobic anticancer drugs and preparation method thereof |
| 01/10/2008 | US20080008754 Pharmaceutical Compositions Comprising (+)-(2S,3S)-2-(3-Chlorophenyl)-3,5,5-Trimethyl-2-Morpholinol |
| 01/10/2008 | US20080008753 Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
| 01/10/2008 | US20080008752 Pharmaceutical compositions of memantine |
| 01/10/2008 | US20080008751 Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof |
| 01/10/2008 | US20080008749 Ceramide composition and method of use |
| 01/10/2008 | US20080008748 Method for treating pain using a substituted 2-aminotetralin compound |
| 01/10/2008 | US20080008746 Compositions and method for treatment of Attention Deficit Disorder and Attention Deficit/Hyperactivity Disorder with methylphenidate |
| 01/10/2008 | US20080008745 Transdermal delivery of naltrexone hydrochloride, naltrexol hydrochloride, and bis(hydroxy-methyl)propionyl-3-0 ester naltrexone using microneedles |
| 01/10/2008 | US20080008744 Novel tissue support |
| 01/10/2008 | US20080008743 Orally Dissolving Formulations of Memantine |
| 01/10/2008 | US20080008741 Methods of Treating Irritable Bowel Syndrome |
| 01/10/2008 | US20080008740 Pharmaceutical Composition for Rectal, or Vaginal Application, Method of Manufacturing and Use as Medicament Thereof |
| 01/10/2008 | US20080008738 Flexible bioresorbable hemostatic packing and stent |
| 01/10/2008 | US20080008736 Random copolymers of methacrylates and acrylates |
| 01/10/2008 | US20080008727 Compositions comprising adapalene dissolved with cyclodextrins |
| 01/10/2008 | US20080008723 comprising a conserved di-glucosyl -tri-heptosyl inner-core moiety ; Actinobacillus pleuropneumoniae (Ap), Mannheimia haemolytica (Mh) and Pasteurella multocida (Pm); toxoids |
| 01/10/2008 | US20080008720 Substituted Tricyclic Heterocycles and their Uses |
| 01/10/2008 | US20080008708 Tyrosine kinase inhibitors |
| 01/10/2008 | US20080008694 Methods to prevent and treat diseases |
| 01/10/2008 | US20080008685 Viral vectors |
| 01/10/2008 | US20080008682 Agonists; Treatment of Hepatitis C virus; combination with other drugs; phosphonate derivatives of purine or thiazolo(4,5-d)pyrimidine rings |
| 01/10/2008 | US20080008681 Macrocyclic hepatitis c virus serine protease inhibitors |
| 01/10/2008 | US20080008679 Osteoinduction-assisting composition |
| 01/10/2008 | US20080008668 Personal care compositions with glycerin and hydroxypropyl quaternary ammonium salts |
| 01/10/2008 | US20080008666 Breath Test for Oral Malodor |
| 01/10/2008 | US20080008662 Aerosol Drug Inhibition of Lung Cancer |
| 01/10/2008 | US20080008661 Methods and compositions for treating erectile dysfunction |
| 01/10/2008 | US20080008660 Antimicrobially active compounds for treating bad breath |
| 01/10/2008 | US20080007840 Optical apparatus and methods for chemical analysis |
| 01/10/2008 | US20080006115 Shifter with actuator incorporating magnetic unlock mechanism |
| 01/10/2008 | US20080006112 Shifter with actuator incorporating shape memory alloy |
| 01/10/2008 | DE102006059317A1 Verfahren zur Herstellung von β-Amino-α-hydroxy-carbonsäureamiden Process for the preparation of β-amino-α-hydroxy-carboxylic acid amides |
| 01/10/2008 | DE102006031176A1 Substituierte Benzoxepino-isoxazole und ihre Verwendung Substituted benzoxepino-isoxazoles and their use |
| 01/10/2008 | DE102006031175A1 Wässrige Arzneimittelformulierung von 4-[((4-Carboxybutyl)-(2[(4-phenethyl-benzyl)oxy]-phenethyl)amino)methyl]benzoesäur An aqueous pharmaceutical formulation of 4 - [((4-carboxybutyl) - (2 [(4-phenethyl-benzyl) oxy] phenethyl) amino) methyl] benzoesäur |
| 01/10/2008 | DE10109466B4 Verfahren und Mittel zur Modifikation humaner Angiogenese Method and means for modification of human angiogenesis |
| 01/10/2008 | DE10015463B4 Creme in Form einer überwässerten Wasser-in-Öl-Emulsion Cream in the form of a überwässerten water-in-oil emulsion |
| 01/10/2008 | CA2856344A1 Pharmaceutical composition containing a tetrahydrofolic acid |
| 01/10/2008 | CA2836316A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | CA2775940A1 Catheter balloon with polymeric coating |
| 01/10/2008 | CA2697784A1 Novel regimens for treating diseases and disorders |
| 01/10/2008 | CA2693064A1 Therapeutic delivery of carbon monoxide |
| 01/10/2008 | CA2692430A1 Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures |
| 01/10/2008 | CA2692428A1 Methods for preventing, postponing or improving the outcome of invasive spinal procedures |
| 01/10/2008 | CA2665788A1 Pharmaceutical preparations for contraception and for preventing the risk of congenital malformations |
| 01/10/2008 | CA2664399A1 Use of hypothermia inducing drugs |
| 01/10/2008 | CA2660182A1 Dioxo-alkanes and dioxo-alkenes compounds |
| 01/10/2008 | CA2660031A1 Pyrazole derivatives as cytochrome p450 inhibitors |
| 01/10/2008 | CA2659060A1 Fused heterocyclic inhibitors of d-amino acid oxidase |
| 01/10/2008 | CA2658001A1 Novel glucokinase activators and methods of using same |
| 01/10/2008 | CA2657702A1 Quinazolines and related heterocyclic comp0unds, and their therapeutic use |
| 01/10/2008 | CA2657103A1 Novel belactosin derivatives as therapeutic agents/biological probes and their synthesis |
| 01/10/2008 | CA2657093A1 Bicyclic heteroaryl inhibitors of pde4 |
| 01/10/2008 | CA2657051A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/10/2008 | CA2657035A1 Novel inhibitors of hepatitis c virus replication |
| 01/10/2008 | CA2656989A1 Methods to prevent and treat diseases |
| 01/10/2008 | CA2656959A1 Prophylactic or therapeutic agent for viral disease |
| 01/10/2008 | CA2656936A1 Novel compounds |
| 01/10/2008 | CA2656929A1 Triazine derivative compound and composition for treating cancer containing them |
| 01/10/2008 | CA2656905A1 Azaindole derivatives with a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition |
| 01/10/2008 | CA2656903A1 An oral pharmaceutical composition of anilinopyrimidine, preparation and use thereof |
| 01/10/2008 | CA2656851A1 Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity |
| 01/10/2008 | CA2656706A1 Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereof |
| 01/10/2008 | CA2656703A1 Agent containing chrysin and cholic acid for reducing weight, accelerating lipid catabolism, and/or restricting calories |
| 01/10/2008 | CA2656680A1 Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| 01/10/2008 | CA2656633A1 Substituted benzoxepinoisoxazoles and the use thereof |
| 01/10/2008 | CA2656630A1 Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl]benzoic acid |
| 01/10/2008 | CA2656627A1 Sulfamatobenzothiophene derivatives |
| 01/10/2008 | CA2656623A1 Modulators of metabolism and the treatment of disorders related thereto |
| 01/10/2008 | CA2656622A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | CA2656618A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | CA2656617A1 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof |
| 01/10/2008 | CA2656597A1 New pyridine analogues |
| 01/10/2008 | CA2656566A1 Dihydrofuro pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | CA2656549A1 Medicament for the enhancement of cognitive function and neuroprotection |
| 01/10/2008 | CA2656540A1 Ibuprofen-containing liquid filled hard capsules |
| 01/10/2008 | CA2656520A1 Modulators of metabolism and the treatment of disorders related thereto |
| 01/10/2008 | CA2656502A1 Compounds having a potentiating effect on the activity of ethionamide and uses thereof |
| 01/10/2008 | CA2656458A1 Indazole derivatives for the treatment of hsp90-induced diseases |
| 01/10/2008 | CA2656427A1 Modulators of toll-like receptor 7 |
| 01/10/2008 | CA2656398A1 Substituted piperidines that increase p53 activity and the uses thereof |
| 01/10/2008 | CA2656395A1 Immediate-release tablet formulations of a thrombin receptor antagonist |
| 01/10/2008 | CA2656393A1 Method of using substituted piperidines that increase p53 activity |
| 01/10/2008 | CA2656366A1 Combination of hmg-coa reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases |
| 01/10/2008 | CA2656364A1 Dihydrothieno pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | CA2656363A1 Use of derivatives of imidazo[1, 2-a]pyridine-2-carboxamides in therapeutics |
| 01/10/2008 | CA2656356A1 Antiviral phosphinate compounds |
| 01/10/2008 | CA2656311A1 Ultra pure epa and polar lipids produced in largely heterotrophic culture field |
| 01/10/2008 | CA2656307A1 Use of 1,4-diaryldihydropyrimidin-2-one derivatives for the treatment of pulmonary arterial hypertension |
| 01/10/2008 | CA2656290A1 Methods of using igf1r and abl kinase modulators |
| 01/10/2008 | CA2656270A1 Solid dose formulations of a thrombin receptor antagonist |
| 01/10/2008 | CA2656265A1 Synthesis of diethyl{ i5" (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs |
| 01/10/2008 | CA2656202A1 Treatment of neurodegenerative diseases through inhibition of hsp90 |
| 01/10/2008 | CA2656183A1 Modulators of muscarinic receptors |